Medication info
Neomazole 40 mg (Esomeprazole Magnesium Trihydrate)

Neomazole 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
PTP - 28 tablets/box [14 tablets/Alu-Alu X 2]
Approval status
Active

MFDS item code 201506666 · Approved 2015.09.21 · Insurance code 652903830

Summary

Main use
Treatment of acid-related disorders (e.g., reflux and Zollinger-Ellison syndrome), H. pylori infection, ulcers, and drug-induced gastrointestinal symptoms
Who uses it
Adults · Children
Adult dosage
Directions for use: This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have improved, subsequent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. On-demand use is not recommended to control subsequent symptoms in patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment. 4. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients No dosage adjustment is necessary.
Children's dosage
2. Adolescents aged 12 years or older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have improved, subsequent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. On-demand use is not recommended to control subsequent symptoms in patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 3. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., reflux and Zollinger-Ellison syndrome), H. pylori infection, ulcers, and drug-induced gastrointestinal symptoms

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • Helicobacter pylori positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers confirmed to be associated with Helicobacter pylori infection. It is effective as a short-term therapy for the treatment of gastrointestinal pain, discomfort, burning sensation, and other symptoms related to the use of non-steroidal anti-inflammatory drugs. Additionally, it is used for the treatment and prevention of gastric ulcers in patients requiring continuous use of non-steroidal anti-inflammatory drugs. This medication is effectively used for a variety of gastrointestinal disorders.

Dosage and Administration

Adult dosage

Directions for use: This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have improved, subsequent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. On-demand use is not recommended to control subsequent symptoms in patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment. 4. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients No dosage adjustment is necessary.

Children's dosage

2. Adolescents aged 12 years or older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have improved, subsequent symptoms should be controlled by administering 20 mg once daily. · In adults, 20 mg once daily may be taken as needed. On-demand use is not recommended to control subsequent symptoms in patients at high risk of gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 3. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. Patients with hypersensitivity to this drug or its components, or to benzimidazole derivatives, should not use it. In addition, when used in combination with amoxicillin or clarithromycin for the eradication of Helicobacter pylori, it should not be given to patients who have hypersensitivity to penicillin antibiotics or macrolide antibiotics. Patients who are taking specific heart-related medications, or those taking atazanavir and nelfinavir, nursing mothers, and patients with a history of myocardial infarction should not use this medication. This medication may cause various adverse reactions. Gastrointestinal symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting are frequently reported, with rare occurrences of blood abnormalities, skin rashes, liver function abnormalities, and neurological symptoms. Very rarely, serious adverse effects such as severe skin reactions or rhabdomyolysis may occur, so medical advice should be sought immediately if symptoms occur. Regular monitoring is important during long-term use. Particularly, with prolonged use exceeding one year, blood magnesium levels may be decreased, necessitating periodic monitoring. Additionally, as this medication inhibits gastric acid secretion, it may increase the risk of bacterial overgrowth in the gastrointestinal tract; therefore, if symptoms such as diarrhea persist, notify medical personnel. This medication may interact with other drugs. Changes in blood concentration can affect the efficacy of other medications, especially when used in conjunction with warfarin, phenytoin, diazepam, methotrexate, atazanavir, etc., so caution is required. Additionally, when used with certain antibiotics, it may affect the heart, so it must be used strictly according to a doctor's instructions. The safety of this medication during pregnancy has not been fully established, so it should be used with caution; it is advisable not to take this medication while nursing. In cases of overdose, there is no specific antidote, so appropriate treatment should be administered according to symptoms. This medication is not removed by dialysis, so care should be taken. Finally, this medication should be stored out of reach of children, and transferring it to other containers is not recommended as it may negatively affect quality.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, sensory disturbance, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, tachycardia, flushing, hypertension, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal hemorrhage, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered olfaction, taste loss, parageusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric adenomatous polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air or moisture exposure. It is important to maintain storage temperatures between 1° and 30°C to ensure the drug's effectiveness.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

PTP - 28 tablets/box [14 tablets/Alu-Alu X 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.